Point72 (Difc) LTD I Teos Therapeutics, Inc. Transaction History
Point72 (Difc) LTD
- $2.72 Trillion
- Q4 2024
A detailed history of Point72 (Difc) LTD transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 8,794 shares of ITOS stock, worth $65,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,794
Previous 2,999
193.23%
Holding current value
$65,515
Previous $30.6 Million
120.56%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ITOS
# of Institutions
148Shares Held
33.3MCall Options Held
454KPut Options Held
2.45M-
Black Rock Inc. New York, NY3.73MShares$27.8 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$20.4 Million16.91% of portfolio
-
Bvf Inc San Francisco, CA2.33MShares$17.3 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.09MShares$15.6 Million0.26% of portfolio
-
Jpmorgan Chase & CO New York, NY2.07MShares$15.4 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $265M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...